Innovent Biologics Inc (6IB) — Net Asset Quality Index
Innovent Biologics Inc (6IB) has a Net Asset Quality Index of 51.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €37.35 Billion minus total liabilities of €17.99 Billion yields net assets of €19.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Innovent Biologics Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Innovent Biologics Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Innovent Biologics Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 51.8%, representing net assets of €19.36 Billion against total assets of €37.35 Billion EUR. See working capital position of Innovent Biologics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Innovent Biologics Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Innovent Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Innovent Biologics Inc worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.8% | €19.36 Billion | €37.35 Billion | €17.99 Billion | ▼ -8.9 pp |
| 2024 | 60.7% | €13.12 Billion | €21.60 Billion | €8.48 Billion | ▼ 0.0 pp |
| 2023 | 60.7% | €12.53 Billion | €20.63 Billion | €8.10 Billion | ▼ -0.3 pp |
| 2022 | 61.0% | €10.73 Billion | €17.59 Billion | €6.86 Billion | ▼ -2.6 pp |
| 2021 | 63.6% | €10.33 Billion | €16.24 Billion | €5.91 Billion | ▼ -10.6 pp |
| 2020 | 74.2% | €8.78 Billion | €11.83 Billion | €3.06 Billion | ▲ +8.4 pp |
| 2019 | 65.8% | €4.76 Billion | €7.23 Billion | €2.47 Billion | ▼ -2.8 pp |
| 2018 | 68.6% | €4.19 Billion | €6.11 Billion | €1.92 Billion | ▲ +134.6 pp |
| 2017 | -66.0% | €-1.62 Billion | €2.46 Billion | €4.08 Billion | ▼ -32.0 pp |
| 2016 | -34.0% | €-958.22 Million | €2.82 Billion | €3.77 Billion | — |